Nciph ERIC2
Nciph ERIC2
Second Edition
A second characteristic of data description, distribution, refers the alternative hypothesis is that there is a difference in
to the frequencies or probabilities with which values occur the mean blood pressure of the standard treatment and
within our population. Discrete data are often represented new drug group following therapy. The alternative
graphically with bar graphs like the one below (Figure 1). hypothesis might also be described as your "best guess"
as to what the values are.
Earlier, we indicated that we can reject the null hypothesis To evaluate if drug Z reduces mean systolic blood
pressure, a randomized clinical trial will be performed
if the probability of obtaining a sample like the one where 12 individuals receive drug Z and 8 receive a
observed in our study is sufficiently small. You may ask placebo. The null hypothesis to be tested is that there
What is sufficiently small? How small is determined by is no difference in the mean systolic blood pressure of the
experimental and placebo groups. The alternative
how willing we are to reject the null hypothesis when it hypothesis is that there is a difference between the
accurately reflects the population from which it is means of the two groups. The type I error for your trial
sampled. This type of error is called a Type I error. will be 5%.
This error is also commonly called alpha (). Alpha is the
probability of rejecting the null hypothesis when the null is Results
true. This probability is selected by the researcher and is Below is the group assignments and resulting systolic
typically set at 0.05. It is important to remember that this blood pressure (SBP)
is an arbitrary cut-point and should be taken into
Patient Assignment Systolic BP
consideration when making conclusions about the results
of the study. 1 Drug Z 100
3 Drug Z 110
There is a second type of error that can be made during
statistical testing. It is known as Type II error, which is the 5 Drug Z 122
probability of not rejecting the null when the alternative 7 Drug Z 109
hypothesis is indeed true, or in other words, failing to 9 Drug Z 108
reject the null when the null hypothesis is false. Type II
11 Drug Z 111
error is commonly known as . Beta relates to another
13 Drug Z 118
important parameter in statistical testing which is power.
Power is equal to (1-) and is essentially the ability to 15 Drug Z 105
avoid making a type II error. Like , power is also defined 17 Drug Z 115
by the researcher, and is typically set at 0.80. Below is a 18 Drug Z 119
schematic of the relationships between , and power.
19 Drug Z 106
20 Drug Z 109
2 Placebo 129
Decision Truth
Null True Null False 4 Placebo 125
10 Placebo 135
Students T test 12 Placebo 134
This test is most commonly used to test the difference between 14 Placebo 140
the means of the dependent variables of two groups. For
example, this test would be appropriate if one wanted to 16 Placebo 128
evaluate whether or not a new anti-hypertensive drug reduces
mean systolic blood pressure.
meandrug = 100 + 110 + + 109 = 111 mm Hg
12
Now that we have determined the difference between t= -21 - 0 = -7.8 = |-7.8| = 7.8
means, we need to determine the standard error for that 2.69
difference which is calculated using the pooled estimate of
We now compare our calculated value to a table of critical
the variance (2).
values for the Students' T distribution (found in most
The formula for the standard error of the drug Z group is: basic statistics books). The table also requires that we
know the degrees of freedom and the value of a we have
selected. Degrees of freedom (df) refers to the amount of
2drug = (SBPdrug meandrug)2 = information that a sample has in estimating the variance.
ndrug - 1 It is generally the sample size minus one. The df for our
calculation is 12 + 8 - 2 = 18 (the sample size for each
2drug =[(100-111)2 + (110-111)2 + ...+ (109-111)2] = 40.9 group - 1). With a two tailed a of 0.05, our value |-7.8|
12-1 is greater than the critical value from the table (2.101).
Thus, we can reject the null hypothesis that there is no
The standard error for the placebo group is calculated in difference between mean blood pressure levels, and
the same manner substituting the values for the placebo accept, by elimination, our alternative hypothesis.
group.
Here we have the contingency table with data from our With this information, we can now calculate the 2
trial: statistic:
2 = (Observedi - Expectedi)2
Greater Satisfaction?
Expectedi
Social Worker Yes No Total
Visit?
Yes 64 46 90 2 = (64-55)2 + (46-55)2 + (36-45)2 + (54-45)2
55 55 45 45
No 36 54 110
In chi-square analysis we are testing the null hypothesis The chi-square statistic for these data has approximately 1
that there is no association between a social worker visit degree of freedom, an of 0.05, and it is compared to the
and a greater satisfaction with care. critical values on standard Chi-square table. Note that
the degrees of freedom would increase as the number of
Generally, in evaluating this type of data, it is important for rows and columns of our tables increases (for instance a 3
each of the individual cells to have large values, (i.e. X 4 table). Since our calculated value (2 = 6.545) is
greater than 5 or 10 each), If these conditions are not met, greater than the critical value (3.841), we can once again
a special type of chi-square analysis is conducted called reject the null hypothesis that there is no association
the Fishers exact test. This will not be discussed in this between the exposure and the outcome of interest, and
notebook. conclude that in this case seeing a social worker is
To calculate the chi-square statistic (2 ): significantly associated with a greater satisfaction with
care.
Thus, we now have a table that has both the actual and Categorical Data Analysis, Using the SAS System by ME
expected (in parentheses) values: Stokes, CS Davis, and GG Koch. SAS Institute Inc., Cary,
Greater Satisfaction? NC, 2001.
Social Worker Yes No Total
Visit?
Yes 64 (55) 46 (55) 90
No 36 (45) 54 (45) 110
Practice Questions
Acknowledgement
Answers are at the end of this notebook The authors of the Second Edition of the ERIC Notebook
would like to acknowledge the authors of t he
Researchers are conducting a study of the association ERIC N ot ebook, First Edition: Michel Ib rahim ,
between working in a noisy job environment and hearing MD, PhD, Lorraine Alexander, DrPH, Carl Shy,
loss. The researchers null hypothesis is that there is no MD, DrPH and Sherry Farr, GRA, Depart m ent of
difference in hearing loss between people who work in a Epidem iology at t he Univers it y of N ort h Carolina
noisy job environment compared with people who work in at Chapel Hill. The First Edition of the ERIC
a quiet job environment. The researchers alternative N ot eb ook was produced b y t he Educat ional Arm
hypothesis is that there is a difference in hearing loss of the Epidem iologic Res earch and Inform at ion
between people who work in a noisy job environment Cent er at Durham, N C. The funding for the ERIC
compared with people who work in a quiet job N ot eb ook First Edit ion was provided b y t he
environment. The researchers decided to set their alpha Departm ent of V et erans Affairs (DV A), V et erans
level at 0.05. The researchers analysis results show a p- Healt h Adm inist rat ion (V HA), Cooperat ive
value of 0.0003 (please note that for the purposes of this St udies Program (CSP) to prom ot e the s t rat egic
question you are being provided with just the p-value from growt h of the epidemiologic capacit y of t he
the study when in reality a study analysis is much more DV A.
complex).
References
Answer: True
Answer: False
Answer: True
Answer: False